The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The demand of transplant diagnostics is increasing repuily.
The global Transplant Diagnostics market was valued at US$ 3848.6 million in 2023 and is anticipated to reach US$ 5609 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transplant Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplant Diagnostics.
Report Scope
The Transplant Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transplant Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transplant Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- BD
- Biofortuna
- Biomérieux SA
- Bio-Rad Laboratories
- Caredx
- F. Hoffman-La Roche
- Gendx
- Hologic
- Illumina
- Immucor
- Luminex
- Merck KGaA
- Omixon
- Qiagen
- Thermo Fisher Scientific
Segment by Type
- Solid Organ Transplantation
- Stem Cell Transplantation
- Soft Tissue Transplantation
- Bone Marrow Transplantation
Segment by Application
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transplant Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transplant Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Solid Organ Transplantation
1.2.3 Stem Cell Transplantation
1.2.4 Soft Tissue Transplantation
1.2.5 Bone Marrow Transplantation
1.3 Market by Application
1.3.1 Global Transplant Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Independent Reference Laboratories
1.3.3 Hospitals & Transplant Centers
1.3.4 Research Laboratories & Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transplant Diagnostics Market Perspective (2019-2030)
2.2 Transplant Diagnostics Growth Trends by Region
2.2.1 Global Transplant Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transplant Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Transplant Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Transplant Diagnostics Market Dynamics
2.3.1 Transplant Diagnostics Industry Trends
2.3.2 Transplant Diagnostics Market Drivers
2.3.3 Transplant Diagnostics Market Challenges
2.3.4 Transplant Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transplant Diagnostics Players by Revenue
3.1.1 Global Top Transplant Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Transplant Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transplant Diagnostics Revenue
3.4 Global Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplant Diagnostics Revenue in 2023
3.5 Transplant Diagnostics Key Players Head office and Area Served
3.6 Key Players Transplant Diagnostics Product Solution and Service
3.7 Date of Enter into Transplant Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transplant Diagnostics Breakdown Data by Type
4.1 Global Transplant Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Transplant Diagnostics Forecasted Market Size by Type (2025-2030)
5 Transplant Diagnostics Breakdown Data by Application
5.1 Global Transplant Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Transplant Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transplant Diagnostics Market Size (2019-2030)
6.2 North America Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transplant Diagnostics Market Size by Country (2019-2024)
6.4 North America Transplant Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transplant Diagnostics Market Size (2019-2030)
7.2 Europe Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transplant Diagnostics Market Size by Country (2019-2024)
7.4 Europe Transplant Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transplant Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Transplant Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transplant Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Transplant Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transplant Diagnostics Market Size (2019-2030)
9.2 Latin America Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transplant Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Transplant Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transplant Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Transplant Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transplant Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Transplant Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Transplant Diagnostics Introduction
11.1.4 BD Revenue in Transplant Diagnostics Business (2019-2024)
11.1.5 BD Recent Development
11.2 Biofortuna
11.2.1 Biofortuna Company Detail
11.2.2 Biofortuna Business Overview
11.2.3 Biofortuna Transplant Diagnostics Introduction
11.2.4 Biofortuna Revenue in Transplant Diagnostics Business (2019-2024)
11.2.5 Biofortuna Recent Development
11.3 Biomérieux SA
11.3.1 Biomérieux SA Company Detail
11.3.2 Biomérieux SA Business Overview
11.3.3 Biomérieux SA Transplant Diagnostics Introduction
11.3.4 Biomérieux SA Revenue in Transplant Diagnostics Business (2019-2024)
11.3.5 Biomérieux SA Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Transplant Diagnostics Introduction
11.4.4 Bio-Rad Laboratories Revenue in Transplant Diagnostics Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Caredx
11.5.1 Caredx Company Detail
11.5.2 Caredx Business Overview
11.5.3 Caredx Transplant Diagnostics Introduction
11.5.4 Caredx Revenue in Transplant Diagnostics Business (2019-2024)
11.5.5 Caredx Recent Development
11.6 F. Hoffman-La Roche
11.6.1 F. Hoffman-La Roche Company Detail
11.6.2 F. Hoffman-La Roche Business Overview
11.6.3 F. Hoffman-La Roche Transplant Diagnostics Introduction
11.6.4 F. Hoffman-La Roche Revenue in Transplant Diagnostics Business (2019-2024)
11.6.5 F. Hoffman-La Roche Recent Development
11.7 Gendx
11.7.1 Gendx Company Detail
11.7.2 Gendx Business Overview
11.7.3 Gendx Transplant Diagnostics Introduction
11.7.4 Gendx Revenue in Transplant Diagnostics Business (2019-2024)
11.7.5 Gendx Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Transplant Diagnostics Introduction
11.8.4 Hologic Revenue in Transplant Diagnostics Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Transplant Diagnostics Introduction
11.9.4 Illumina Revenue in Transplant Diagnostics Business (2019-2024)
11.9.5 Illumina Recent Development
11.10 Immucor
11.10.1 Immucor Company Detail
11.10.2 Immucor Business Overview
11.10.3 Immucor Transplant Diagnostics Introduction
11.10.4 Immucor Revenue in Transplant Diagnostics Business (2019-2024)
11.10.5 Immucor Recent Development
11.11 Luminex
11.11.1 Luminex Company Detail
11.11.2 Luminex Business Overview
11.11.3 Luminex Transplant Diagnostics Introduction
11.11.4 Luminex Revenue in Transplant Diagnostics Business (2019-2024)
11.11.5 Luminex Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Detail
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Transplant Diagnostics Introduction
11.12.4 Merck KGaA Revenue in Transplant Diagnostics Business (2019-2024)
11.12.5 Merck KGaA Recent Development
11.13 Omixon
11.13.1 Omixon Company Detail
11.13.2 Omixon Business Overview
11.13.3 Omixon Transplant Diagnostics Introduction
11.13.4 Omixon Revenue in Transplant Diagnostics Business (2019-2024)
11.13.5 Omixon Recent Development
11.14 Qiagen
11.14.1 Qiagen Company Detail
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Transplant Diagnostics Introduction
11.14.4 Qiagen Revenue in Transplant Diagnostics Business (2019-2024)
11.14.5 Qiagen Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Transplant Diagnostics Introduction
11.15.4 Thermo Fisher Scientific Revenue in Transplant Diagnostics Business (2019-2024)
11.15.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
